Laurus Labs Share Price
Know More₹1,025.95 14.05 (1.39%)
5-Dec-2025₹1,026.10 12.60 (1.24%)
5-Dec-2025BSE : 540222
NSE : LAURUSLABS
Sector : Health care
ISIN Code : INE947Q01028
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 05-Dec-2025
| Market Cap (₹ Cr) | 55,386 |
Traded Value (₹ Cr) | 1.85 |
Volume (Shares) | 18,015 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,040.00 |
52-Week High Date | 01-Dec-2025 |
52-Week Low (₹) | 504.30 |
52-Week Low Date | 28-Jan-2025 |
All Time High (₹) | 1,040.00 |
All Time High Date | 01-Dec-2025 |
All Time Low (₹) | 59.60 |
All Time Low Date | 07-Aug-2019 |
Laurus Labs Ltd
Laurus Labs Ltd News
Laurus Labs Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 55,394 |
| EPS - TTM (₹) [C] | 12.63 |
| P/E Ratio (X) [C] | 81.24 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 40.00 |
| Latest Dividend Date | 31-Oct-2025 |
| Dividend Yield (%) | 0.12 |
| Book Value Share (₹) [C] | 89.01 |
| P/B Ratio (₹) [C] | 11.53 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Multi Asset Allocation Fund (G) | 47.65 | 4,61,969 | 0.73 |
| UTI-Multi Asset Allocation Fund (IDCW) | 47.65 | 4,61,969 | 0.73 |
| UTI-Multi Asset Allocation Fund - Direct (G) | 47.65 | 4,61,969 | 0.73 |
| UTI-Multi Asset Allocation Fund - Direct (IDCW) | 47.65 | 4,61,969 | 0.73 |
| UTI-Arbitrage Fund (G) | 19.11 | 1,85,300 | 0.18 |
| UTI-Arbitrage Fund (IDCW) | 19.11 | 1,85,300 | 0.18 |
| UTI-Arbitrage Fund - Direct (G) | 19.11 | 1,85,300 | 0.18 |
| UTI-Arbitrage Fund - Direct (IDCW) | 19.11 | 1,85,300 | 0.18 |
Research Reports
Stock Strength
| Today's Low/High (₹) | 1,005.80 1,028.50 |
| Week Low/High (₹) | 1,001.60 1,040.00 |
| Month Low/High (₹) | 970.25 1,040.00 |
| Year Low/High (₹) | 501.15 1,040.00 |
| All time Low/High (₹) | 59.60 1,040.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.51% | -0.51% | 0.01% | -0.06% |
| 1 Month | 4.38% | 4.37% | 2.70% | 2.30% |
| 3 Month | 16.46% | 16.52% | 6.20% | 5.84% |
| 6 Month | 60.17% | 60.17% | 5.24% | 5.80% |
| 1 Year | 74.46% | 74.40% | 4.83% | 5.98% |
| 3 Year | 143.99% | 144.02% | 36.41% | 40.03% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru
Registered Office: Plot No 21 Jawaharlal Nehru, Pharma City Parawada,Visakhapatnam,Andhra Pradesh-531021 Ph: 91-891-3061222
FAQs about Laurus Labs Ltd
1. What's the Laurus Labs Ltd share price today?
Laurus Labs Ltd share price was Rs 1,025.95 at close on 5th Dec 2025. Laurus Labs Ltd share price was up by 1.39% over the previous closing price of Rs 1,011.90. Laurus Labs Ltd share price trend:
- Last 1 Month: Laurus Labs Ltd share price moved up by 4.38% on BSE.
- Last 3 Months: Laurus Labs Ltd share price moved up by 16.46% on BSE.
- Last 12 Months: Laurus Labs Ltd share price moved up by 74.46% on BSE.
- Last 3 Years: Laurus Labs Ltd share price moved up by 143.99% on BSE.
2. How can I quickly analyse the performance of the Laurus Labs Ltd stock?
The performance of the Laurus Labs Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 81.24
- Price to book value ratio is 11.53
- Dividend yield of 0.12
- The EPS (trailing 12 months) of the Laurus Labs Ltd stock is Rs 12.63
3. What is the market cap of Laurus Labs Ltd?
Laurus Labs Ltd has a market capitalisation of Rs 55,386 crore.
4. What is Laurus Labs Ltd's 52-week high/low share price?
The Laurus Labs Ltd’s 52-week high share price is Rs 1,040.00 and 52-week low share price is Rs 504.30.
5. Is the Laurus Labs Ltd profitable?
On a consolidated basis, Laurus Labs Ltd reported a profit of Rs 193.75 crore on a total income of Rs 1,680.43 crore for the quarter ended 2025.
6. Which are Laurus Labs Ltd’s peers in the Health care sector?
Laurus Labs Ltd’s top 5 peers in the Health care sector are Alkem Lab, Abbott India, Glenmark Pharma., Laurus Labs, Biocon, Glaxosmi. Pharma, Ipca Labs..
7. Who owns how much in Laurus Labs Ltd?
Key changes to the Laurus Labs Ltd shareholding are as follows:
- Promoter holding in Laurus Labs Ltd has gone down to 27.59 per cent as of Sep 2025 from 27.62 per cent as of Dec 2024.
